Helicobacter Pylori Infection
390
34
41
194
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
27 trials with published results (7%)
Research Maturity
194 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
1.5%
6 terminated out of 390 trials
97.0%
+10.5% vs benchmark
45%
177 trials in Phase 3/4
14%
27 of 194 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 194 completed trials
Clinical Trials (390)
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
New Strategy for the Detection and Treatment of Helicobacter Pylori Infections in Primary Care Guided by a Non-invasive PCR in Stool
Tegoprazan-containing Sequential for H. Pylori
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity
Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound
Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study
Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.
H. Pylori Eradication With Argon Plasma During Endoscopy
Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication
Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy
The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change
Fecal Molecular Susceptibility-guided Hp Rescue Therapy
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile